Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceutical Industries Limited (TEVA) Q4 2022 Earnings Call Transcript
12:21pm, Wednesday, 08'th Feb 2023
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q4 2022 Earnings Conference Call February 8, 2023 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Head of Investor Relations Richa
Why Teva Pharmaceutical Stock Is Sliding Today
12:01pm, Wednesday, 08'th Feb 2023
Investors were disappointed with the drugmaker's 2023 outlook.
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026
10:21am, Wednesday, 08'th Feb 2023 The Motley Fool
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite.
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026
05:21am, Wednesday, 08'th Feb 2023
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite.
Biotech Stocks Reward Shareholders Who Handle The Bumpy Ride
02:56pm, Friday, 27'th Jan 2023
Biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulted over 41%.
Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
02:40pm, Friday, 27'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
11:17am, Friday, 27'th Jan 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
02:22pm, Thursday, 26'th Jan 2023 The Motley Fool
Things aren't as bad as they might seem.
6 Great Stocks to Buy in 2023 and Hold Forever
11:31am, Thursday, 26'th Jan 2023 The Motley Fool
I own all six great businesses and don't plan to sell a single share.
6 Great Stocks to Buy in 2023 and Hold Forever
06:31am, Thursday, 26'th Jan 2023
I own all six great businesses and don't plan to sell a single share.
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
10:21am, Wednesday, 25'th Jan 2023 The Motley Fool
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.
Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025
05:21am, Wednesday, 25'th Jan 2023
A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.
Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
05:26pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
Catalyst Pharmaceuticals (CPRX) receives a notice letter stating that Teva Pharmaceuticals has filed an application to the FDA seeking approval for a generic version of Firdapse.
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
03:01pm, Thursday, 19'th Jan 2023 Benzinga
Upgrades
For Coeur Mining Inc (NYSE:CDE), Canaccord Genuity upgraded the previous rating of Sell to Hold. In the third quarter, Coeur Mining showed an EPS of $0.16, compared to $0.01 from the year-ago
Analyst Ratings for Teva Pharmaceutical Indus
02:01pm, Thursday, 19'th Jan 2023 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with underst
